Real-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study)

G. Procopio; A. Bamias; M. Schmidinger; R. Hawkins; A. Rodriguez Sanchez; S. Vazquez; N. Srihari; H. Kalofonos; P. Bono; C. Pisal; Y. Hirschberg; L. Dezzani; Q. Ahmad; C. Suarez Rodriguez; E. Jonasch

doi:10.1093/annonc/mdy283.093

Real-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study)

G. Procopio, A. Bamias, M. Schmidinger, R. Hawkins, A. Rodriguez Sanchez, S. Vazquez, N. Srihari, H. Kalofonos, P. Bono, C. Pisal, Y. Hirschberg, L. Dezzani, Q. Ahmad, C. Suarez Rodriguez, E. Jonasch

Genitourinary Medical Oncology

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	viii313
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy283.093
State	Published - Oct 1 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdy283.093

Cite this

Procopio, G., Bamias, A., Schmidinger, M., Hawkins, R., Rodriguez Sanchez, A., Vazquez, S., Srihari, N., Kalofonos, H., Bono, P., Pisal, C., Hirschberg, Y., Dezzani, L., Ahmad, Q., Suarez Rodriguez, C., & Jonasch, E. (2018). Real-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study). Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii313. https://doi.org/10.1093/annonc/mdy283.093

Real-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study). / Procopio, G.; Bamias, A.; Schmidinger, M. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii313.

Research output: Contribution to journal › Article › peer-review

Procopio, G, Bamias, A, Schmidinger, M, Hawkins, R, Rodriguez Sanchez, A, Vazquez, S, Srihari, N, Kalofonos, H, Bono, P, Pisal, C, Hirschberg, Y, Dezzani, L, Ahmad, Q, Suarez Rodriguez, C & Jonasch, E 2018, 'Real-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study)', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii313. https://doi.org/10.1093/annonc/mdy283.093

@article{6b7648b469b6485ea5d10941a10f5aa4,

title = "Real-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study)",

author = "G. Procopio and A. Bamias and M. Schmidinger and R. Hawkins and {Rodriguez Sanchez}, A. and S. Vazquez and N. Srihari and H. Kalofonos and P. Bono and C. Pisal and Y. Hirschberg and L. Dezzani and Q. Ahmad and {Suarez Rodriguez}, C. and E. Jonasch",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy283.093",

language = "English (US)",

volume = "29",

pages = "viii313",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Real-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study)

AU - Procopio, G.

AU - Bamias, A.

AU - Schmidinger, M.

AU - Hawkins, R.

AU - Rodriguez Sanchez, A.

AU - Vazquez, S.

AU - Srihari, N.

AU - Kalofonos, H.

AU - Bono, P.

AU - Pisal, C.

AU - Hirschberg, Y.

AU - Dezzani, L.

AU - Ahmad, Q.

AU - Suarez Rodriguez, C.

AU - Jonasch, E.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85073837905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073837905&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy283.093

DO - 10.1093/annonc/mdy283.093

M3 - Article

C2 - 32136729

SN - 0923-7534

VL - 29

SP - viii313

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

Real-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this